The effect of mirabegron, a potent and selective β₃-adrenoceptor agonist, on the pharmacokinetics of CYP2D6 substrates desipramine and metoprolol

By Krauwinkel Walter   Dickinson James   Schaddelee Marloes   Meijer John   Tretter Reiner   Wetering Jeroen   Strabach Gregory   Gelderen Marcel  

European Journal of Drug Metabolism and Pharmacokinetics, Vol. 39, Iss. 1, 2014-03 ,pp. : 43-52

Springer Publishing Company

Access to resources Recommend Favorite

Prejunctional actions of methylenedioxymethamphetamine in vas deferens from wild-type and 2A/D -adrenoceptor knockout mice

By Rajamani K.   Leong S.   Lavelle A.   Docherty J.R.  

European Journal of Pharmacology, Vol. 423, Iss. 2, 2001-07 ,pp. : 223-228

Elsevier

Access to resources Recommend Favorite

Responsiveness to noradrenaline in aorta from wild-type, nitric oxide synthase-2, nitric oxide synthase-3 and 2A/D -adrenoceptor knockout mice

By Vandeputte C.   Aiden McCormick P.   Docherty J.R.  

European Journal of Pharmacology, Vol. 466, Iss. 1, 2003-04 ,pp. : 129-136

Elsevier

Access to resources Recommend Favorite

Inhibitory effects of H-antihistamines on CYP2D6- and CYP2C9-mediated drug metabolic reactions in human liver microsomes

By He Nu   Zhang Wen-Qi   Shockley Dolores   Edeki Timi  

European Journal of Clinical Pharmacology, Vol. 57, Iss. 12, 2002-02 ,pp. : 847-851

Springer Publishing Company

Access to resources Recommend Favorite

Characterization of the CYP2D6 gene locus and metabolic activity in Indo- and Afro-Trinidadians: discovery of novel allelic variants

By Montané Jaime Lazara Karelia   Lalla Anthony   Steimer Werner   Gaedigk Andrea  

Pharmacogenomics, Vol. 14, Iss. 3, 2013-02 ,pp. : 261-276

Future Medicine

Access to resources Recommend Favorite